Financial statements Astrazeneca Pharma Poland
Balance sheet of Astrazeneca Pharma Poland
Company age:
Age:
23 y. 3 m. 22 d.
Share capital:
Share capital:
50 000 PLN
Balance sheet data of ASTRAZENECA PHARMA POLAND
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Total assets | 203 095,00 | 276 865,00 | 309 196,00 | 454 157,00 | 609 745,80 | 812 336,00 |
| A. Fixed assets | 22 059,00 | 26 369,00 | 21 109,00 | 29 045,00 | 41 972,30 | 56 290,10 |
| B. Current assets | 181 036,00 | 250 496,00 | 288 087,00 | 425 112,00 | 567 773,50 | 756 045,90 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| Total liabilities | 203 095,00 | 276 865,00 | 309 196,00 | 454 157,00 | 609 745,80 | 812 336,00 |
| A. Equity | 96 229,00 | 142 665,00 | 195 379,00 | 262 049,00 | 362 996,80 | 489 734,50 |
| B. Liabilities and provisions for liabilities | 106 866,00 | 134 200,00 | 113 817,00 | 192 108,00 | 246 749,00 | 322 601,50 |
| I. Long-term liabilities | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| II. Short-term liabilities | 19 809,00 | 34 538,00 | 28 331,00 | 42 832,00 | 60 652,20 | 87 444,90 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.